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2571Acute Increase of
Cardiac Output Reduces
Central Sleep Apneas in
Heart Failure PatientsCentral sleep apnea (CSA) is reported in advanced
heart failure (HF) (1). At least 3 factors have been sug-
gested to play a pivotal role in CSA pathogenesis,
speciﬁcally hyperventilation, which is the likely
consequence of an enhanced stimulation of intra-
pulmonary receptors; low cardiac output leading to
increased circulatory delay; and carbon dioxide cere-
brovascular reactivity (1). The increased circulatory
delay from the lungs to peripheral receptors imposes a
temporary misalignment between chemical signals
and ventilation (1). Although suggested, a role of low
cardiac output in CSA pathogenesis has little support-
ing evidence. Indeed, no signiﬁcant differences in
cardiac output or in circulatory delay have been found
between patients with HF with and without CSA (2).
Left ventricular assist devices (LVAD) are used to
treat patients with severe HF. In some cases, LVAD
blood ﬂow can be increased simply by increasing
LVAD pump speed. However, because pump ﬂow is
pre- and post-load dependent, a precise relationship
between pump speed and blood ﬂow changes cannot
be anticipated (3).
We analyzed the effect of pump speed changes on
blood ﬂow in 17 patients (mean age 61.3  7 years)
who successfully underwent LVAD (Jarvik 2000;
Jarvik Heart, New York, New York) implantation,
as measured by inert gas rebreathing technology
(Innocor; Innovision, Odense, Denmark) (4), on res-
piratory function and ventilation during sleep. The
Jarvik 2000 has 5 different settings for rotational
speeds, allowing progressively greater pump ﬂow.
On the ﬁrst day, patients (pump speed 3) under-
went clinical, laboratory, echocardiographic, and
spirometric (including alveolar-capillary diffusion
[DL] for nitric oxide and carbon monoxide) as-
sessments and cardiopulmonary exercise testing
(SensorMedics, Yorba Linda, California). Thereafter,
patients were studied with pump speed randomly
set at 2 or 4 in the following sequence: clinical
monitoring for a few hours to conﬁrm hemody-
namic stability, 5-channel portable polysomnography
(Embletta X100; Embla Systems, Pleasanton, Califor-
nia), and, the following morning, cardiac output at
rest, spirometry, DLCO, and DLNO. Thereafter, mea-
surements were repeated with the same sequence
after changing the pump speed. Spirometry andcardiopulmonary exercise testing at pump speed
3 showed a restrictive defect with moderate to severe
DL reduction and relevant exercise impairment.
Changing pump speed induced trivial spirometric
and DL changes. Cardiac output was 3.26  0.94 l/min
and 3.63  1.08 l/min (p ¼ 0.03) with pump speed set
at 2 and 4, respectively. Polysomnography showed
a time in bed of 475  53 min and 504  31 min
(p ¼ 0.07) and oxygen saturation signal integrity
(time with evaluable oxygen saturation signal) of 78.8
 19.6% and 53.6  28.1% of recording (p < 0.01) at
speeds 2 and 4, the latter probably due to difﬁculty
reading oxygen saturation in the absence of pulsatile
ﬂow. Increasing cardiac output (speed 4) decreased
apnea-hypopnea index (AHI) (from 20.7  16.3 to
11.85  10.38, p ¼ 0.008), hypopnea index (from 6.7 
4.4 to 2.7  2.7, p < 0.001), and CSA, but not
obstructive or mixed apnea (Figure 1). Patients with
the highest AHI and CSA were those with the greater
reduction at pump speed 4. In the 6 patients with
greater CSA index reduction (>1/h), CSA decrease was
related to cardiac output changes (R2 ¼ 0.4949).
Increasing pump speed caused reductions in Cheyne-
Stokes respiration in all patients (from 44.5  13.4%
to 23.0  23.0%, p < 0.05).
Circulatory delay and cardiac output did not
correlate, nor did their changes, with the 2 pump
speeds. Similarly, no correlation was detected be-
tween cardiac output and circulatory delay and AHI
and CSA. A few reasons may explain this ﬁnding.
First, cardiac output was by necessity measured
during the waking state with patients in a sitting
position, whereas circulatory delay was measured
during sleep with patients lying in bed. Thus, the
hemodynamic pattern was likely different. Moreover,
patients with HF with elevated AHI and several CSAs
have the same cardiac output and circulatory delay
as patients who do not show these ﬁndings (1).
However, patients with circulatory delay reductions
>10% had greater AHI and CSA reductions and a trend
toward greater cardiac output increases. Changing
pump speed from 2 to 4 increased cardiac output by
about 10%. The increased cardiac output did not in-
ﬂuence lung mechanics and DL, but it signiﬁcantly
reduced sleep-related breathing disorders, with a
>50% reduction of AHI, due to hypopnea and CSA
reduction. Accordingly, changes in AHI are unlikely
related to changes in pulmonary receptor stimulation.
All reported observations conﬁrm the dependence of
CSA but not of obstructive and mixed apneas on
cardiac output. However, it should be emphasized
that both cardiac output and circulatory delay were
not directly linked to AHI or CSA, showing that low
cardiac output and high circulatory delay are among
FIGURE 1 Sleep Apneas With Left Ventricular Assist Device Pump Speeds 2 and 4
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(Left) Central sleep apnea index. (Right) Obstructive apnea index. #p ¼ 0.007. LVAD ¼ left ventricular assist device.
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2572the triggers needed for the presence of AHI and CSA
in patients with HF but, by themselves, not sufﬁcient
to trigger CSA (1). It is unknown if the presence of
high AHI and CSA is associated with a worse prog-
nosis in LVAD patients, as it is in patients with HF.
However, this is a likely possibility, given that AHI
and CSA are associated with worsening of HF and
with sudden cardiac death. It is possible that regu-
lating nighttime LVAD pump speed to promote better
breathing during sleep is a worthwhile practice.*Piergiuseppe Agostoni, MD, PhD
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Rehabilitation Referral
A Universal ProblemPharmacological guideline–recommended therapies
(i.e., aspirin, statins) are prescribed in >90% of
patients undergoing percutaneous coronary in-
terventions (PCIs); however, cardiac rehabilitation
(CR) referral occurs in only 60% of these patients.
Using CathPCI Registry data, Aragam et al. (1)
demonstrated that this “CR referral gap” is endemic,
with hospital characteristics being highly inﬂuential,
patient factors playing less of a role, and insurance
status the least inﬂuential. Whether this is a reﬂection
of the U.S. health care system or an international
phenomenon requires further consideration.
